TIER IV to develop large-scale dataset for autonomous driving under NEDO project
TOKYO, Dec. 26, 2025 /PRNewswire/ -- TIER IV, a pioneer in open-source software for autonomous driving, has been selected by the Japanese government's New Energy and Industrial Technology Development Organization (NEDO) for an initiative aimed at...
HKSH Medical Group Signed Memorandum of Understanding with Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen To Advance Precision Proton Therapy, Furthering the Healthy China Initiative
HONG KONG, Dec. 24, 2025 /PRNewswire/ -- In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center, HKSH Medical Group ("HKSH") and Cancer Hospital Chinese Academy of Medical Sciences,...
P+Ex and Post-Tensioning Institute Unite to Advance Sustainability
COLUMBIA, Md., Dec. 22, 2025 /PRNewswire/ -- P+Ex, the Center of Excellence for Concrete Preservation and Service Life Extension, is proud to announce a new strategic partnership with the Post-Tensioning Institute (PTI), bringing together two...
EquiLend Invests in Digital Prime Technologies to Advance Institutional Tokenized-Asset and Digital-Markets Infrastructure
Partnership aligns EquiLend's infrastructure with tokenized assets, digital securities and stablecoins, delivering connectivity across Trading, Post-Trade and Data & Analytics to address evolving market structure and client workflow needs NEW...
MEDI&GENE Announces Catalyze Agreement with Lilly to Advance Next-Generation Obesity Therapeutics
SEOUL, South Korea, Dec. 17, 2025 /PRNewswire/ -- MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreement with Eli Lilly and Company (Lilly) to advance...
Banking Academy of Vietnam and Vantage Foundation Formalised Strategic Partnership to Advance Financial Education
HANOI, Vietnam, Dec. 17, 2025 /PRNewswire/ -- The Banking Academy of Vietnam (BAV) and Vantage Foundation officially formalised a strategic partnership through the signing of a Memorandum of Understanding (MoU) at a signing ceremony held at the...
Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery
ADELAIDE, Australia, Dec. 17, 2025 /PRNewswire/ -- Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells...
Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development
The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with strong backing from both new investors and existing supporters Proceeds to advance two differentiated and highly...
Leadgene Biosolutions, Inc., (Formerly CYTENA BPS), Announces Corporate Rebranding to Mark a New Phase of Growth within the Leadgene Group
TAIPEI, Dec. 15, 2025 /PRNewswire/ -- Leadgene Biosolutions, Inc. (formerly CYTENA BPS), following its transition out of the BICO Group, now officially integrates with Leadgene Biomedical, a biotechnology company specializing in recombinant...
Minghui Pharmaceutical Announces FDA clearance of IND to Initiate Global Phase Ⅲ Trials of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Thyroid Eye Disease
SHANGHAI and HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced the U.S. Food and Drug...